General Information：

Date: June 17th, 2022 – June 18th

Estimated number of participants: 500 persons

Location: Shanghai, China

Co-organizer: 

Chinese Anti-Cancer Association (CACA)

Sino-American Pharmaceutical Professionals Association – Greater Philadelphia (SAPA-GP)

OBiO Technology (Shanghai) Corp., Ltd.

As an academic conference laser-focusing on the oncolytic virus, this con-ference will invite 30+ leading scientists, enterprise executives, regulatory reviewers, consultants, and industry experts in the field of oncolytic virus. The event aims to capture the trends and challenges in oncolytic virother-apy development and regulatory policies, exchanging the innovations and solutions in large-scale manufacturing, combination therapy, key clinical progress, and the future of commercialization. Through this hybrid event, we are bringing together experts worldwide and exploring the new breakthrough and possibilities of oncolytic virus therapy.

Conference Agenda：